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Background: Aim of the study was the validation of the Bipolar Disorder Rating Scale
(BDRS) in an Italian population. Secondary aim was the evaluation of differences between
unipolar and bipolar depression and between bipolar I and II depressed patients.
Method: 125 Bipolar Disorder and 60 Major Depressive Disorder patients were
administered an Italian translation of the BDRS (I-BDRS), Hamilton Depression Rating
Scale (HDRS), Montgomery-Asberg Depression Rating Scale (MADRS), Young Mania
Rating Scale (YMRS) and Temperament and Character Inventory-Revised (TCI-R).
Results: I-BDRS showed considerable validity and reliability. Factor analysis found 3
subscales, two linked to depressive symptoms and one to mixed symptoms. Measures
concerning depression (MADRS and HAM-D) were positively related to the I-BDRS’s
subscales, but mostly to the two subscales measuring depression. In mixed symptoms,
the mean of the bipolar group was significantly higher than the unipolar group suggesting
that the BDRS was able to distinguish between unipolar and bipolar depressed patients.
Conclusion: I-BDRS is a valid scale for the measurement of depression in BD patients,
with a notable internal consistency (Cronbach’s α 0.82), a significant consistency
between items/total (Cronbach’s α from 0.80 to 0.82) and positive correlation with other
scales (MADRS r = 0.67, p < 0.001; HDRS r = 0.81, p < 0.001; YMRS r = 0.46
p < 0.0001). The mixed state sub-scale shows usefulness in differentiating bipolar from
unipolar patients. I-BDRS could be a sensitive tool, both in pure depression and in mixed
states, and could be used in the everyday screening and treatment of Bipolar Disorder.
Keywords: bipolar disorder, bipolar depression rating scale, validation, unipolar, depression, mixed state, mania
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INTRODUCTION
Although mania or hypomania are considered the
pathognomonic characteristics of bipolar disorder (BD),
depression is more common than manic symptoms during
lifetime of bipolar patients (Judd et al., 2002). Hence,
psychometric instruments for the assessment of bipolar
depressive symptoms have a capital role in both clinical
research and everyday psychiatric practice. Apart from Bipolar
Depression Rating Scale (Berk et al., 2007), other scales have
been largely developed and validated on unipolar depressed
patients and lack of sensitivity and accuracy to discriminate
different psychopathological nuances of bipolar disorder. Bipolar
depression, indeed, has its own unique and distinct clinical
profile that differs from unipolar depression. Bipolar patients
not only spend most of their time suffering from syndromal or
sub-syndromal depression (Judd et al., 2002), but their depressive
symptoms are even greater in bipolar II disorder (Judd et al.,
2003). The lifetime prevalence of bipolar spectrum disorder is
4.5% (instead of 16.2% of major depressive disorder, MDD)
(Kessler et al., 2003; Merikangas et al., 2011), with an equal
gender distribution, except for bipolar II disorder that is more
common in females (Nivoli et al., 2011). Age of onset is earlier
(average 6 years before compared to major depression) with
episodes of illness that tend to be shorter and highly relapsing,
abrupt beginning and sudden end (Weissman et al., 1996). Rate
of suicidality is higher, with a lifetime prevalence of 17% in
bipolar I disorder and 24% in bipolar II disorder, compared to
12% in unipolar depression (Rihmer and Kiss, 2002; Kessler
et al., 2005). With regard to clinical presentation, individuals
with bipolar disorder are more likely to report atypical depressive
features, psychosomatic reactions and mood reactivity (Angst
and Sellaro, 2000; Goodwin and Jamison, 2007), with symptoms
such as hypersomnia, hyperphagia and pressured speech (Cuellar
et al., 2005). Psychotic aspects and substance abuse are frequent
especially in young people (Tohen et al., 1998; Mitchell et al.,
2001; Joslyn et al., 2016).
Bipolar depression is often entangled by the presence of
sub-threshold manic symptoms (so-called “mixed depression”),
occurring in approximately 49.5% of Bipolar II patients (Benazzi,
2004a). According to the bipolar spectrum notion, these
symptoms are common, dimensional and frequently recurring
(Perugi et al., 2001; Benazzi, 2004b; Moreno and Andrade,
2005). Their presence can significantly affect the course of the
disease (Goldberg et al., 2009), with a growing tendency toward
the destabilization of mood (Goldberg et al., 2007), recurrent
syndromes (Perlis et al., 2006) and an increased rate of suicidality
(Goldberg et al., 1998). Recent evidence suggests that mixed
states, even in their sub-threshold forms, can influence the
course and outcome of bipolar depression in the medium term,
compared to the “pure” form of the disease (Dodd et al., 2010;
Mazza et al., 2011) and there is a substantial impact on overall
functioning, social relationships and perceived well-being (Mazza
et al., 2011). It seems that mixed states may be underestimated
by both clinicians and patients, leading to a decrease of the rate
of recognition and the possibility of establishing a more specific
treatment (Mazza et al., 2012).
Psychometric scales normally used for the evaluation of
depressive symptoms, such asHamiltonDepression Rating Scale-
HDRS (Hamilton, 1960) and Montgomery Asberg Depression
Rating Scale-MADRS (Montgomery and Asberg, 1979), are
also used to assess BD patients, but lack in distinguishing
bipolar depression, expecially with mixed and atypical symptoms
(Hantouche and Akiskal, 2005; Serretti and Olgiati, 2005).
The Bipolar Depression Rating Scale (BDRS) is a purpose-
built instrument (Berk et al., 2007) designed to capture the unique
clinical characteristics of bipolar depression. It is a useful tool not
only for research but also in daily practice. The scale consists of
20 items, each with a score from 0 to 3 for a maximum total of
60 points. A semi-structured interview has been built together
with the instrument, in order to limit the variability between test
administrators using standardized anchor-points.
The aim of our study is the validation and the reliability
of BDRS in an Italian sample of bipolar patients. We built
an inter-university collaborative group (Catholic University
of Scared Heart of Rome; University of Bari; University of
Florence; University of Bologna; Libera Università degli Studi
Maria SS. Assunta-LUMSA of Rome) in order to decrease the
chance of validation biases, such as heterogeneity of patients,
different recruitment possibilities (outpatients and inpatients)
and the variability of symptom manifestations, concordant with
significant socioeconomic differences between North and South
of Italy (Pompili et al., 2008).
The main purpose of the present study was the validation
of BDRS among an Italian population for use both for research
and in everyday clinical activity. The secondary aim was
the evaluation, among separate clinical samples, of differences
between unipolar and bipolar depression and between bipolar I
and II depression. Finally, we investigated temperamental and
character features in different samples of depressed patients with
Cloninger’s TCI (Martinotti et al., 2008), in order to find any
common personological trait of bipolar depression as previously
inspected by some authors (Cloninger et al., 1998; Harley et al.,
2011)
MATERIALS AND METHODS
The study was conducted in accordance with the latest revision
of the Declaration of Helsinki and the rules of Good Clinical
Practice (ICH-GCP). The Institutional Ethical and Review Board
of the Catholic University of Sacred Heart in Rome approved
the study with protocol (P/521/CE/2011). All subjects provided
written informed consent after a complete description of the
study procedures and participated without receiving any form of
payment.
The I-BDRS
In order to achieve comparability between the Italian translation
of BDRS and the original instrument, we used a multiple-
phase translation process based on the 5 cross-cultural criteria
of Flaherty (Flaherty et al., 1998) and general guidelines for
translating study instruments. Firstly two independent teams
(Rome and Bari) translated the original scale into Italian; then the
translations were compared and integrated into a single version.
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The next step was a back translation into English by a native
speaker, followed by a consistency check by the original authors.
The Italian version of the BDRS, as the original instrument,
consists of 20 items each with a score ranging from 0 to 3, with a
minimum of 0 and a maximum score of 60.
Study Sample
Subjects were recruited from July 2011 to July 2015 among
outpatients referred to the Bipolar Disorder Unit of the A.
Gemelli Hospital in Rome and among inpatients and outpatients
admitted to the Psychiatric Ward of the Hospital Policlinico
Consorziale in Bari.
Inclusion criteria were: (Judd et al., 2002) currently meeting
DSM-IV-TR criteria for Bipolar Disorder I (BP-I), Bipolar
Disorder II (BP-II) (2) age 18–75 years; (3) current experience
of depressive symptoms (but not necessarily fulfilling criteria
for a major depressive episode); (4) native Italian speakers, with
mastery of spoken and written Italian language.
Subject were excluded if any of the following conditions were
present: (1) a diagnosis of mental retardation or documented
IQ < 70; (2) any other DSM diagnosis (3) unstable general
medical conditions; (3) clinically significant pre-study physical
exam, electrocardiogram, laboratory or urinalysis abnormalities
indicating serious medical disease impairing evaluation; (4)
pregnant or breast-feeding women. A sample of patients with a
current diagnosis of Major Depressive Disorder (MDD), fulfilling
the same inclusion/exclusion criteria was recruited.
At evaluation, patients followed a naturalistic maintenance
treatment, with typical or atypical antipsychotics (Asenapine,
Aripiprazole, Clotiapine, Clozapine, Haloperidole, Olanzapine,
Quetiapine, Risperidone, and Paliperidone), mood stabilizers
or antiepileptic drugs (Lithium, Valproate, Carbamazepine,
Lamotrigine, and Oxcarbazepine), antidepressants (SSRI,
SNRI, NaSSA, and other unspecific antidepressants) and
Benzodiazepines or Hypnotics.
Procedure
A BP diagnosis was established by trained psychiatrists using the
Structured Clinical Interview for DSM-IVAxis I Disorder (SCID-
I) (First et al., 1996). Personality disorders were excluded through
the Structured Clinical Interview for DSM-IV Axis II Disorders
(SCID-II) (First et al., 1997). An anamnestic interview was
administered in order to obtain sociodemographic information
and psychiatric history.
All participants were interviewed by specifically trained
psychiatrists using the Bipolar Depression Rating Scale (BDRS),
HDRS 21-item version (HAM-D), Montgomery Asberg
Depression Rating Scale (MADRS) and Young Mania Rating
Scale (YMRS). Good inter-rate reliability has been found on
all instruments (Fleiss’ coefficient 0.82). Patients were further
interviewed using the Italian version of the Temperament and
Character Inventory revised version (TCI-R), a self-administered
interview for personality characteristics (Martinotti et al., 2008).
Anonymity was guaranteed to all the participants: data were
de-identified before any further data manipulation from the
coordinating center of the Catholic University of the Sacred
Heart. Then the database was sent to the University of Bologna,
University of Florence and the LUMSA University of Rome for
the statistical analysis, ensuring an adequate level of protection
using a double level of data encryption.
Statistical Analysis
The distribution of the I-BDRS scores was performed, in order
to test whether each item had a normal distribution, using the
Kolmogorov-Smirnov one-sample test (K–S test). Descriptive
statistics and Pearson’s correlation tests between the different
rating scales were also used. A distribution can be considered
approximately normal whether skewness and kurtosis indices
are between −1 and +1 (Joanes and Gill, 1998). Pearson’s
correlation coefficients between I-BDRS sub-scales, MADRS,
HAM-D and YMRS were calculated to assess the convergent
validity. In order to test discriminant validity, Student t-tests
for independent samples were carried out between the bipolar
sample and unipolar sample.
Then an exploratory factor analysis (EFA) was carried out of
the I-BDRS through the principal component analysis method
using IBM SPSS Statistics 21 software. To test sampling adequacy,
we measured Kaiser–Meyer–Olkin (KMO) and Bartlett’s test of
sphericity. A sample can be considered numerically adequate
when KMO is close to 1 or Bartlett’s test is significant. The
number of components extracted was based on the percentage
of variance accounted for by the Kaiser-Guttman method and,
overall, the scree plot (Mazza et al., 2012). After the selection
of the number of components, we verified, by the means of
the communality matrix, whether the factor model adequately
represented each of the initial variables (each variable should
have a score ≥0.10; a score <0.10 indicates that the variable is
not properly reproduced in the factor solution). Subsequently,
we verified the component loading of each variable, using the
component loading matrix, in order to organize and accomunate
each item with his latent factor consinstency. Then we performed
a confirmatory factor analysis and carried out structural equation
modeling by the use of M-PLUS. This analysis allows to test the
goodness of the factor structure emerging from an exploratory
model. To test the goodness of fit, we considered absolute fit
indices as standardized root mean square residual (SRMR) and
root mean square error adjustment (RMSEA) and incremental fit
indices as comparative fit index (CFI), incremental fit index (IFI)
and non-normed fit index (NNFI). Furthermore, we considered
chi-square divided by degrees of freedom (χ2/df). As suggested
by Byrne (Byrne, 1998), a model can be considered reasonably
standard if SRMR and RMSEA are lower than 0.08, if CFI, IFI,
and NNFI are higher than 0.90 and if χ2/df is <3.
The Internal consistency reliability of the scale was tested
through Cronbach’s alpha coefficient and, in order to explore
further variables, it was calculated separately for gender and for
each subtype of BD. For Cronbach’s alpha interpretation, George
and Mallery (George and Mallery, 2003) provided the following
rules: α > 0.9= Excellent, α > 0.8=Good, α > 0.7=Acceptable,
α > 0.6 = Questionable, α > 0.5 = Poor, and α < 0.5 =
Unacceptable.
The analysis of variance (ANOVA) was used to correlate the
scores of specific sub-groups, distinguishing between BD I, BD
II and unipolar patients. Finally, considering that we had more
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than two raters, the inter-rater reliability was measured using
Fleiss’ coefficient (which measures the agreement between a fixed
number of raters) instead of the classic Cohen’s kappa (valid only
on two raters), by the independent rating of five audio-recorded
interviews.
RESULTS
Demographic and Clinical Data
On a total of 250 subjects consecutively screened, 188 patients
were selected using the aforementioned criteria. Among 188
depressed patients, 63 meet criteria for MDD (33.3%), 62 for
BD I (32.8%), and 63 for BD II (33.3%); 14 patients (7.4%)
display some significantmanic symptoms (YMRS≥12) indicating
a mixed state. Bipolar patients gender ratio is 55M/69F whilst
in unipolar depression there are more woman (17M/46M) and
the age of onset differ from 28.3 years old of bipolar disorder vs.
38.7 years old of major depression. Other clinical characteristics
of the sample are shown in Table 1, detailed for different types of
depression (Bipolar and Unipolar) and sites of screening. Table 2
shows pharmacological treatment.
Distribution of Items
Mean, standard deviation, skewness and kurtosis for each
item were calculated, in order to test whether the distribution
is approximately normal (see Figure 1 and Table 3). Results
showed that no item had extreme means or standard deviation
close to zero; furthermore, skewness and kurtosis were between
−1 and +1, except that for six items for which they were slightly
lower or higher. These results suggested that the item distribution
could be considered approximately normal.
TABLE 1 | Clinical characteristics of the sample.
VARIABLES Bipolar disorder Major depressive disorder
Rome
( n = 84)
Bari
(n = 41)
Total sample
( n = 125)
Rome
( n = 43)
Bari
( n = 20)
Total sample
( n = 63)
Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD
Gender, Male/Female 35/48 20/21 55/69 15/28 2/18 17/46
Diagnosis, BD I/BD II 24/60 38/3 63/62
Age (years) 50.2 ± 10.8 41.2 ± 11.3 47.2 ± 11.7 52.2 ± 12.2 52.1 ± 11.0 52.2 ± 11.8
Marital status (engaged/not engaged) 47/37 16/25 63/62 24/19 12/8 36/27
Education (years) 13.4 ± 3.4 9.4 ± 3.3 12.1 ± 3.8 13.4 ± 3.2 10.0 ± 2.9 12.9 ± 3.44
Employment (employed/not employed) 52/32 20/21 72/53 21/22 12/8 29/34
Age at onset (years) 28.9 ± 10.1 27.2 ± 9.1 28.3 ± 9.7 41.3 ± 13.5 33.3 ± 11.1 38.7 ± 13.2
Duration of illness (years) 20.8 ± 10.9 14 ± 11.3 18.3 ± 11.6 7.5 ± 4.5 14 ± 11 11.8 ± 9.7
Mood episodes (n*) 9.1 ± 7.7 6.9 ± 6.9 8.3 ± 7.5 3 ± 1.2 1 ± 1 1 ± 1.6
MADRS score 18.3 ± 8.3 29.5 ± 8.4 21.9 ± 9.8 23.6 ± 9.1 27.5 ± 7.1 26.2 ± 7.8
HAM-D score 17.9 ± 7.8 23.1 ± 4.6 19.6 ± 7.3 23 ± 8.70 22 ± 5.4 22.3 ± 6.4
YMRS score 5.4 ± 5.61 6.02 ± 3.27 5.6 ± 4.9 2.4 ± 1.1 4.5 ± 2.6 3.8 ± 2.4
I-BDRS score 21.1 ± 9.08 28.2 ± 5.14 23.5 ± 8.6 24.8 ± 6 28.7 ± 7.8 27.5 ± 7.4
I-BDRS, Italian Bipolar Depression Rating Scale; HAM-D, Hamilton Depression Rating Scale; YMRS, Young Mania Rating Scale, MADRS, Montgomery Asberg Depression Rating Scale.
*Statistically significant.
TABLE 2 | Psychopharmacological treatments.
Bipolar disorder Major depressive disorder
Rome
( n = 84)
Bari
(n = 41)
Total sample
( n = 125)
Rome
( n = 43)
Bari
( n = 20)
Total sample
( n = 63)
Lithium 17 13 30 2 1 3
Mood stabilizers 66 22 88 9 0 9
Antipsychotics 44 30 74 6 5 11
Tryciclics 6 6 12 4 2 6
SSRI 18 14 32 28 11 39
MAOI 6 4 10 0 0 0
SNRI 12 6 18 6 7 13
Dopaminergic drugs 13 6 19 10 3 13
Benzodiazepines 42 20 62 5 10 15
Other drugs 17 0 17 4 0 4
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FIGURE 1 | I-BDRS Scores Distribution.
TABLE 3 | Mean, standard deviation and kurtosis for each item of the I-BDRS.
Mean Standard
deviation
Skewness Kurtosis
1 - Depression 1.77 0.76 −0.46 0.12
2 - Sleep disturbance 1.23 1.04 0.17 −1.23
3 - Appetite disturbance 0.97 1.03 0.51 −1.13
4 - Social impairment 1.62 0.99 0.03 −0.87
5 - Activity/Energy 1.50 0.82 −0.01 −0.49
6 - Motivation 1.46 0.91 0.20 −0.45
7 - Concentration 1.37 0.80 0.30 −0.28
8 - Anxiety 1.92 0.81 −0.60 0.14
9 - Anhedonia 1.60 0.90 −0.20 −0.68
10 - Flattened affect 1.30 0.83 −0.01 −0.65
11 - Worthlessness 1.33 0.92 0.24 −0.74
12 - Helplessness 1.19 0.87 0.29 −0.58
13 - Suicidal ideation 0.50 0.78 1.44 1.26
14 - Guilt 1.38 0.86 0.20 −0.55
15 - Psychotic symptoms 0.62 0.82 1.18 0.56
16 - Irritability 0.72 0.81 0.93 0.23
17 - Lability 1.10 0.85 0.14 −0.95
18 - Motor drive 0.45 0.72 1.55 1.70
19 - Speech 0.46 0.67 1.13 0.07
20 - Agitation 0.96 0.76 0.41 −0.22
A summary statistic of the scales shown a mean of 24.32,
a Standard Deviation of 8.46, with a variance of 71.62. The
Cronbach’s alpha is 0.81 and the Standardized alpha results in
0.82.
Exploratory Factor Analysis
We tested the psychometric properties and the dimensional
structure of the BDRS through the principal component analysis.
In the preliminary analysis, KMO is equal to 0.85 and Bartlett’s
test is significant (χ2
(190)
= 1277.59; p < 0.001), suggesting
our sample results are adequate. The scree plot suggests that
three factors should be extracted; they have eigenvalues > 1
and explain 47.38% of the total variance. Communalities are
observed between 0.19 and 0.66, suggesting that each item
is well-represented by the factorial model. Table 4 shows the
component loading matrix (just loads >0.30), eigenvalues and
the percentages of variance accounted for each dimension.
The first factor was denominated “primary depression
symptoms” because it concerns aspects such as suicidal
ideation, depressed mood, appetite disturbance and impaired
concentration. The second factor was denominated “mixed
symptoms” because it concerns aspects such as lability, increased
motor drive, increased speech or agitation. Finally, third factor
was denominated “secondary depression symptoms” because
it concerns aspects such as reduced motivation, anhedonia,
affective flattening, or worthlessness.
Confirmatory Factor Analysis
On the basis of the results of the component analysis, the
hypothetical model (Figure 2) consists of 3 latent variables
(primary depression symptoms, mixed symptoms and secondary
depression symptoms, represented in the ellipses) and 20
observed variables (the items, represented in a box).
The model reached the following fit indices: SRMR = 0.080,
RMSEA = 0.071, CFI = 0.861, and NNFI = 0.853; furthermore,
the χ2/df was 1.68 (279.77/167). Therefore, the results suggested
that the model fits the data reasonably well, although CFI an d
NNFI were slightly lower than 0.90.
Correlation Between Rating Scales
The Italian BDRS total has strong positive correlation coefficients
with HAM-D (r = 0.81, p < 0.001) and with MADRS (r = 0.67, p
< 0.001) and, in contrast to the original validation sample of Berk
et al. (2007), a good correlation with YMRS (r = 0.46, p < 0.001).
The analysis of variance (ANOVA) between total scores in BD I,
BD II, and MDD patients is shown in Table 5.
Reliability of the Scale
The internal consistency reliability of the scale, assessed by
calculation of Cronbach’s alpha, as mentioned shows that I-BDRS
has a score of 0.82. This good result is coupled with the excellent
values obtained on the total index of skewness and kurtosis,
both below zero with a decline of tails better than average. The
Kolmogorov-Smirnov test gave a similar result (d = 0.057; p =
0.92), confirming a normal distribution (see Figure 1).
In order to explore the possible effect of gender or the impact
of sub-diagnosis on internal consistency of the instrument, the
Cronbach’s alpha of the different subgroups is shown in Table 6.
Pearson’s correlation coefficient between each item and the
total BDRS score (item total correlations) is shown in Table 7: all
items significantly correlated with the total score at the 0.05 level
of significance. For a better understanding of the instrument’s
reliability and sensibility, the same analysis was performed for
the 3 sub-samples (BD I, BD II, and MDD patients), results are
shown in Table 7.
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TABLE 4 | EFA—Component loading matrix, eigenvalues, and the percentages of
variance accounted for each dimension.
Secondary
depression
symptoms
Mixed
symptoms
Primary
depression
symptoms
Motivation 0.80
Anhedonia 0.79
Flattened affect 0.79
Worthlessness 0.66 0.41
Social impairment 0.65
Activity/Energy 0.63 0.39
Guilt 0.38 0.35
Motor drive 0.72
Agitation 0.67
Lability 0.66
Speech 0.65
Irritability 0.64 0.32
Psychotic symptoms 0.55
Suicidal ideation 0.70
Depression 0.33 0.69
Appetite 0.62
Concentration 0.38 0.54
Helplessness 0.49 0.50
Anxiety 0.38 0.45
Sleep 0.33
Eigenvalues 5.58 2.81 1.57
Explained variance 27.88% 14.05% 7.59%
Reliabilty, Convergent and Discriminant
Validity
Table 8 reports the Cronbach’s alpha for each scale of the BDRS
and the Pearson correlations between the BDRS’s subscales and
other measures.
The I-BDRS’s subscales had good internal consistency
coefficients and therefore they can be considered reliable,
as suggested by Cronbach’s alpha coefficients between 0.75
and 0.84. Furthermore, the measures concerning depression
(MADRS and HAM-D) were positively related to the I-BDRS’s
subscales, but mostly to the two subscales measuring depression
(primary and secondary). Similarly, the measure concerning
mania was positively related to I-BDRS’s subscales, but mostly to
subscale measuring mixed symptoms. Moreover I-BDRS scores,
controlling for age and sex, were significantly higher in BD1 (F
= 7.34 p = 0.001). Higher scores in BD I were observed also on
MADRS scores (p < 0.001) and HAMD (p = 0.001). The BD I
group also had higher scores on the YMRS (p < 0.001).
We then tested differences on I-BDRS single items (BD I vs.
BD II vs. MDD), controlling for initial severity, other than age
and sex. In BD I we found significantly higher scores on the
psychotic item (p = 0.001) and agitation item (p = 0.001) whilst
BD II patients scored higher on flattened affect (p = 0.001) and
anhedonia (p = 0.003). MDD patients showed higher scores on
hopelessness (p= 0.002).
Finally, in order to test discriminant validity, we compared the
scores of the bipolar sample with the score of unipolar sample
considering the 3 subscales. In particular, we hypothesized that
the bipolar group would have higher scores than the unipolar
group in terms of mixed symptoms, while there would not be
significantly differences in primary and secondary depression.
The results of t-tests for independent samples supported these
hypotheses; in primary and secondary depression the means of
the bipolar group (M = 1.28 and sd = 0.54; M = 1.45 and sd =
0.64, respectively) were similar to the unipolar group (M = 1.41
and sd = 0.57;M = 1.48 and sd = 0.61, respectively).
In mixed symptoms, the mean of the bipolars group (M =
0.72 and sd = 0.52) was significantly higher (p < 0.05) than
the unipolar group (M = 0.56 and sd = 0.45), suggesting that
the BDRS was able to distinguish between unipolar and bipolar
depressed patients. These positive correlations supported the
convergent and discriminant validity of the I-BDRS.
TCI-R and BDRS Correlation
The correlation between the total score of BDRS and TCI-R
subscales is shown in Table 9. No evident correlation was found
in any of the TCI-R subscales.
DISCUSSION
To the best of our knowledge this is the first published
psychometric study of a scale for the assessment of bipolar
depressive symptoms on an Italian sample.
Validity and Reliability of the Scale
The results show that the I-BDRS is a valid scale for the
measurement of depression in patients with Bipolar Disorder,
with a considerable internal consistency (Cronbach’s α 0.82),
a significant item-total correlations (although in a range from
0.18 to 0.56) and strong positive correlation with the depressive
symptom severity measured by the other administered scales
(MADRS r = 0.67, p < 0.001; HAM-D r = 0.81, p < 0.001;
YMRS r = 0.46 p < 0.0001), including the YMRS (different to
other samples in the literature and to the original validation
sample) (Berk et al., 2007). There is a good inter-rater reliability,
measured by Fleiss’ coefficient with a mean result of 0.81. The
Cronbach’s alpha remains high even in the different subsamples,
confirming that there is no impact of gender as well as Bipolar
I or II diagnosis. These robust results are noteworthy, expecially
when considering the notable representativeness of demographic
distributions of the sample that includes bipolar inpatients and
outpatients, tested in two separated Italian centres, with quite
different catchment areas. The clinical characteristics of the
sample had favorable elements including an even BP I/BP II ratio
(62/63) and expected differences between unipolar and bipolar
patients (higher number of females in MDD, more episodes and
a longer illness in BD), confirming patterns seen in other samples
reported in literature (Weissman et al., 1996; Kessler et al., 2003;
Berk et al., 2007; Mazza et al., 2011, 2012; Nivoli et al., 2011).
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FIGURE 2 | Factor Analysis.
TABLE 5 | ANOVA Total Scores.
MADRS HAM-D YMRS I-BDRS
Mean SD Mean SD Mean SD Mean SD
BD I (n = 62) 26.5 10.3 22.7 7.3 7.4 5.6 27.1 8.2
BD II (n = 63) 17.6 7.2 16.7 6.2 3.8 3.5 20.0 7.7
MDD (n = 63) 51.7 161 23.9 7.2 4.5 3.5 27.5 7.1
F, p 105.5 <0.0001 16.8 <0.0001 16.0 <0.0001 11.2 <0.0001
BD, Bipolar Disorder; I-BDRS, Italian Bipolar Depression Rating Scale; HAM-D, Hamilton Depression Rating Scale; YMRS, Young Mania Rating Scale, MADRS, Montgomery Asberg
Depression Rating Scale; MDD, Major Depressive Disorder.
TABLE 6 | Reliability of the scale.
BD males BD females BD I BD II MDD BD Total
Mean 24.19 ± 7.99 24.33 ± 8.80 27.08 ± 8.16 20.09 ± 7.59 27.62 ± 7.09 24.32 ± 8.46
Variance 63.77 77.41 66.60 57.64 50.32 71.62
Skewness −0.70 −0.27 −0.40 −0.32 −0.06 −0.05
Kurtosis −0.64 −0.62 −0.71 −0.02 −0.15 −0.25
Minimum 2 8 5 2 12 2
Maximum 42 46 46 40 41 46
Cronbach’s α (raw) 0.79 0.83 0.77 0.85 0.77 0.81
Inter-item correlation 0.17 0.21 0.15 0.25 0.16 0.19
Cronbach’s α (stand.) 0.80 0.83 0.77 0.86 0.78 0.82
BD, Bipolar Disorder; MDD, Major Depressive Disorder.
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TABLE 7 | Reliability on different sub-samples.
TOTAL MDD BD 1 BD 2
M SD I-T α M SD I-T α M SD I-T α M SD I-T α
Depression 1.77 0.76 0.21 0.81 0.62 1.08 0.04 0.78 1.90 0.76 0.34 0.76 1.63 0.75 0.62 0.83
Sleep 1.23 1.04 0.23 0.81 0.21 0.49 0.45 0.75 1.58 1.03 0.12 0.78 0.89 0.94 0.43 0.84
Appetite 0.97 1.03 0.34 0.81 2.28 0.53 0.50 0.75 1.24 1.05 0.22 0.77 0.70 0.94 0.23 0.85
Social impair. 1.62 0.99 0.54 0.80 1.41 0.95 0.45 0.75 1.84 1.09 0.56 0.75 1.43 0.82 0.60 0.83
Activity/Energy 1.50 0.82 0.46 0.80 1.34 1.11 0.35 0.76 1.71 0.86 0.42 0.76 1.30 0.73 0.57 0.83
Motivation 1.46 0.91 0.49 0.80 1.83 0.93 0.45 0.75 1.52 1.05 0.40 0.76 1.40 0.75 0.67 0.83
Concentration 1.37 0.80 0.54 0.80 1.86 0.58 0.58 0.75 1.61 0.93 0.50 0.75 1.13 0.55 0.40 0.84
Anxiety 1.92 0.81 0.18 0.82 1.69 0.66 0.10 0.77 1.98 0.91 0.49 0.75 2.02 1.34 0.10 0.87
Anhedonia 1.60 0.90 0.49 0.80 1.86 0.79 0.33 0.76 1.68 1.00 0.51 0.75 1.52 0.78 0.54 0.83
Flattened aff. 1.30 0.83 0.46 0.80 2.10 0.82 0.39 0.75 1.34 0.90 0.30 0.77 1.27 0.75 0.73 0.83
Worthlessness 1.33 0.92 0.53 0.80 1.62 0.90 0.27 0.76 1.50 1.11 0.51 0.75 1.16 0.65 0.65 0.83
Helplessness 1.19 0.87 0.56 0.80 1.41 0.73 0.43 0.75 1.42 0.97 0.54 0.75 1.02 0.73 0.55 0.83
Suicidal ideat. 0.50 0.78 0.40 0.80 1.86 0.88 0.42 0.75 0.65 0.89 0.38 0.76 0.37 0.63 0.36 0.84
Guilt 1.38 0.86 0.50 0.80 1.83 0.80 0.49 0.75 1.61 0.95 0.43 0.76 1.14 0.69 0.42 0.84
Psychotic sym. 0.62 0.82 0.38 0.80 0.86 0.95 0.50 0.74 0.97 0.94 0.19 0.77 0.27 0.48 0.30 0.84
Irritability 0.72 0.81 0.35 0.81 1.62 0.62 0.47 0.75 1.02 0.90 0.18 0.77 0.43 0.59 0.20 0.85
Lability 1.10 0.85 0.26 0.81 0.66 1.04 0.29 0.76 1.32 0.92 0.13 0.78 0.87 0.71 0.42 0.84
Motor drive 0.45 0.72 0.29 0.81 1.03 0.87 0.31 0.76 0.61 0.84 0.03 0.78 0.29 0.55 0.40 0.84
Speech 0.46 0.67 0.21 0.81 1.17 0.80 0.01 0.78 0.60 0.76 0.04 0.78 0.33 0.54 0.28 0.85
Agitation 0.96 0.76 0.26 0.81 0.34 0.61 0.07 0.77 0.98 0.86 0.33 0.76 0.94 0.64 0.57 0.83
BD, Bipolar Disorder; MDD, Major Depressive Disorder; SD, Standard Deviation; I-T, Item Total.
TABLE 8 | Cronbach’s Alpha and the Pearson correlations between the I-BDRS’s
subscales and the other measures.
Secondary depression
symptoms
Mixed
symptoms
Primary depression
symptoms
MADRS 0.70** 0.29** 0.85**
HAM-D 0.72** 0.41** 0.70**
YMRS 0.21* 0.74** 0.20*
α = 0.84 α = 0.75 α = 0.75
HAM-D, Hamilton Depression Rating Scale; YMRS, Young Mania Rating Scale; MADRS,
Montgomery Asberg Depression Rating Scale. *, **Statistically significant.
The I-BDRS Structure
We showed that a three-cluster structure of the instrument is the
most parsimonious model, in line with the original construction
of the scale that included two sections for depression and one for
mixed symptoms.
As with other scales such as the Beck Depression Inventory
(BDI) and other international validations of the BDRS (Galvão
et al., 2013; Sarró et al., 2015) the factors related to a psychological
component of depression (Anhedonia, Reduced Motivation,
Flattened Affect, Worthlessness, Social Impairment, Reduced
Energy) are associated in a specific sub-scale, and the impact
of the core component of depression (Mood, Suicidal Ideation,
Change in Appetite and Sleep) is expressed by another sub-scale.
Other items typical of mixed states (Motor Drive, Agitation,
TABLE 9 | I-BDRS and TCI-R correlations.
R/p R/p R/p R/p
NS1 0. 0019 HA 0.1300 PS4 −0.0232 C2 −0.1046
p = 0.987 p = 0.280 p = 0.847 p = 0.385
NS2 0.0910 RD1 −0.0572 PE 0.0012 C3 −0.1403
p = 0.450 p = 0.635 p = 0.992 p = 0.243
NS3 0.0660 RD2 −0.1340 SD1 −0.0781 C4 −0.0768
p = 0.585 p = 0.265 p = 0.517 p = 0.524
NS4 −0.0320 RD3 0.0727 SD2 −0.2425 C5 −0.0802
p = 0.791 p = 0.547 p = 0.042 p = 0.506
NS 0.0417 RD4 0.0419 SD3 −0.1511 C −0.1184
p = 0.730 p = 0.729 p = 0.208 p = 0.325
HA1 0.2145 RD 0.1945 SD4 −0.1235 ST1 0.0278
p = 0.072 p = 0.104 p = 0.305 p = 0.818
HA2 0.0404 PS1 0.0308 SD5 −0.1366 ST2 −0.0495
p = 0.738 p = 0.799 p = 0.256 p = 0.682
HA3 0.0679 PS2 −0.0692 SD −0.1539 ST3 −0.0123
p = 0.574 p = 0.567 p = 0.200 p = 0.919
HA4 0.0952 PS3 0.0617 C1 −0.1209 ST −0.0098
p = 0.430 p = 0.609 p = 0.315 p = 0.935
NS, Novelty Seeking HA; Harm Avoidance; RD, Reward Dependance; PE, Persistance;
SD, Self Directedness; C, Coperativeness; ST, Self Trascendence.
Lability, increased speech, Irritability and Psychotic Symptoms)
were carried in the same cluster, constituting the subscale for
mixed depression.
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Differences Between BD and MDD
The patterns of item’s mean scores give an indication of how
the symptoms perform in terms of salience for this sample. The
highest mean load fell between the mild and moderate anchor
point. The most highly expressed items were anxiety, anedonia,
social impairment, depressed mood and reduced activity and
the least loaded items were irritability, increased motor drive,
increased speech, and agitation. This is compatible with literature
suggesting that mixed states are present in a significant minority
of individuals with bipolar depression (Benazzi, 2004a).
MDD patients showed higher mean in MADRS and HAM-
D total scores but similar scores on the BDRS compared to
Bipolar Disorders. A possible explanation could be addressed
to the structure of the scales, expecially if we take into
account the results of the item-total correlation of MDD
patients in BDRS: the main factor loading for the total score
is the summary of classical depressive symptoms (like reduced
concentration, helplessness, guilt, social impairment and reduced
motivation) and physical symptoms (linked biological and
circadian rhythms such as appetite and sleep disturbances).
The patterns were completely different among the BD sample,
where the factor loadings exclude appetite and sleep and are
more weighted to mental symptoms and mixed symptoms of
depression.
It is interesting that, in MDD patients, anxious, and pure
depressive symptoms are the lowest contributors to the total:
this could explain the higher scores on the MADRS vs. HAM-
D (considering that MADRS items are more focused on mood
symptoms while HAM-D has more items for evaluation of
anxious symptoms). Regarding the ANOVA symptoms analysis
between BD I and BD II, BD I patients are different in terms
of psychotic symptoms and agitation, while Bipolar II patients
more frequently express anhedonia and flattened affect. MDD
patients are characterized by more hopelessness than BP patients.
Another interesting finding is that unipolar depressed patients
showed a lower load of anxious and pure depressive symptoms
on the total scores of the BDRS, in agreement with other studies
(Katz et al., 1982).
Our study confirmed that anhedonia could have a role
in discriminating between MDD and BD depressed patients,
as reported by several authors (Endicott et al., 1985; Coryell
et al., 1989; Parker et al., 2000). This observation could
be a possible explanation of the fact that, even if the I-
BDRS scores were similar between unipolar depressed patients
and Bipolar I depressed patients, MADRS and HAM-D
scores differed between the two samples. Moreover, Bipolar I
patients showed higher scores on the different psychometric
scales, with similar means compared to those of unipolar
depressed patients (except for MADRS scores that were
higher in unipolar depressed patients with a higher standard
deviation).
As for BDRS item correlation in the different subsamples
it is noted that Bipolar I patients had few factors with
a high loading (social impairment, reduced concentration,
worthlessness, anxiety, helplessness, and guilt) whilst Bipolar
II patients showed a more varied picture with a widespread
factor loading that excludes, as in unipolar depressed patients,
only anxious symptoms. From this point of view, it seems
that Bipolar II depression, excluding mixed symptoms, is more
similar to unipolar depression while Bipolar I depression is
characterized by fewer but more expressed symptoms. Besides,
patients with Bipolar I Depression patients seem to present
more anxiety. It is not clear if depression with psychomotor
activation and anxiety can be ascribed purely to bipolar disorder,
but mixed depression can be represented as a symptomatic
continuum between unipolar depression and mania, with
variable expressions of bipolarity representing dimensions of
underlying pathophysiologic processes (Benazzi, 2007).
Differential Diagnosys Between Bipolar
and Unipolar Depression
As reported in literature (Galvão et al., 2013; Hirschfeld, 2014)
psychometric instruments that can differentiate mixed symptoms
could be very useful in the diffential diagnosis of Bipolar or
Unipolar Depression. A Portuguese version of the BDRS (BDRS-
P) already demonstrated validity in screening bipolar patients
(Galvão et al., 2013). Our study contributes to outline the clinical
usefulness of this instrument and confirms that BD patients score
higher on the mixed symptoms subscale.
Limits of the Study
Although the sample is balanced and thus could be representative
of the different characteristics of the depressed population, we
have not found noticeable associations between the BDRS total
scores and the subscales of the TCI-R.
The limited statistical power may have not allowed us to
detect temperamental and characterial nuances of the patients.
We did however exclude personality disorder, which may have
weakened the capacity to find such factors. The main limitation is
sample size, which reduces the strength of our findings. Another
limitation could be that the assessors were not blind about the
clinical history of each patient. Furthermore, the naturalistic
characterization of the sample might have introduced a number
of confounding factors (e.g., treatment options), though we
systematically controlled for some of them.
CONCLUSIONS
One of the major unfulfilled objectives of psychopathology
is the differentiation of the clinical features of depression
in major depressive disorder and bipolar disorder. A large
body of evidence supports specific qualitative differences in
phenomenology between unipolar and bipolar depression: some
features such as lability and psychomotor retardation may
suggest latent bipolarity (Perugi et al., 2001) and, in addition,
bipolar depression can be characterized by subsyndromal manic
or hypomanic symptoms (Mazza et al., 2011). The challenge
of the diagnosis remains, considering the higher prevalence
of depressive than hypomanic or manic symptoms in bipolar
disorder, and high rates of subthreshold mixed symptoms in
people diagnosed with unipolar depression. Based on these
phenomenological differences we found that the I-BDRS could be
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a sensitive tool, both in pure depression and in mixed states, and
could be used in the everyday screening and treatment of Bipolar
Disorder.
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